Far more than as shields for tumor cells, platelets could also transfer major histocompatibility complex class I and growth factor β (TGF-β) to tumor cells to prevent natural killer cell recognition and inhibit natural killer cell antitumor reactivity, respectively (45, 55, 56). The gene discussed is TGFB1; the disease is neoplasm.